AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (February 5, 2003). doi:10.1152/ajpgi.00347.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/6/G996    most recent
00347.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cho, H. J.
Right arrow Articles by Park, J. H.Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cho, H. J.
Right arrow Articles by Park, J. H.Y.
Submitted on August 19, 2002
Accepted on January 29, 2003

Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in the HT-29 human colon cell line

Han J. Cho1, Woo K. Kim2, Eun J. Kim1, Kyeong C. Jung3, Soochul Park4, Hyun S. Lee1, Angela L. Tyner5, and Jung H.Y. Park1*

1 Division of Life Sciences, Hallym University, Chunchon, Korea, Republic of
2 Food Science and Nutrition, Dankook University, Seoul, Korea, Republic of
3 Department of Pathology, Hallym University, Chunchon, Korea, Republic of
4 Department of Biological Science, Sookmyung Women's University, Seoul, Korea, Republic of
5 Department of Molecular Genetics, University of Ilinois College of Medicine, Chicago, Illinois, USA

* To whom correspondence should be addressed. E-mail: jyoon{at}hallym.ac.kr.

Conjugated linoleic acid (CLA) has chemoprotective properties in experimental cancer models and in vitro studies have shown that CLA inhibits HT-29 colon cancer cell growth. ErbB2 and ErbB3 have been implicated in the development of colon cancer and both proteins are expressed at high levels in the HT-29 cell line. Activation of ErbB2/ErbB3 heterodimers is regulated by the ErbB3 ligand heregulin. To examine CLA regulation of HT-29 cell proliferation and apoptosis and the influence of CLA on the ErbB3 signaling pathway, HT-29 cells were cultured in the presence of CLA and/or heregulin. CLA inhibited DNA synthesis and induced apoptosis of HT-29 cells. While addition of heregulin-{alpha} led to an increase in cell number, it was not able to counteract the negative growth regulatory effect of CLA. Immunoprecipitation/Western blot studies revealed that CLA inhibited heregulin-{alpha}-stimulated phosphorylation of ErbB2 and ErbB3, recruitment of the p85 subunit of phosphoinositide 3-kinase (PI3K) to the ErbB3 receptor, ErbB3-associated PI3K activities, and phosphorylation of Akt. CLA decreased ErbB2 and ErbB3 mRNA and protein levels in a dose-dependent manner. In conclusion, we demonstrate that CLA inhibits cell proliferation and stimulates apoptosis in HT-29 cells, and that this may be mediated by its ability to downregulate ErbB3 signaling and the PI3K/Akt pathway.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
H. J. Choi, M. R. Seon, S. S. Lim, J.-S. Kim, H. S. Chun, and J. H. Y. Park
Hexane/Ethanol Extract of Glycyrrhiza uralensis Licorice Suppresses Doxorubicin-Induced Apoptosis in H9c2 Rat Cardiac Myoblasts
Experimental Biology and Medicine, December 1, 2008; 233(12): 1554 - 1560.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Meng, S. F. Shoemaker, S. O. McGee, and M. M. Ip
t10,c12-Conjugated linoleic acid stimulates mammary tumor progression in Her2/ErbB2 mice through activation of both proliferative and survival pathways
Carcinogenesis, May 1, 2008; 29(5): 1013 - 1021.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. J. Cho, M. R. Seon, Y. M. Lee, J. Kim, J.-K. Kim, S. G. Kim, and J. H. Y. Park
3,3'-Diindolylmethane Suppresses the Inflammatory Response to Lipopolysaccharide in Murine Macrophages
J. Nutr., January 1, 2008; 138(1): 17 - 23.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. J. Kim, S. Y. Park, H.-K. Shin, D. Y. Kwon, Y.-J. Surh, and J. H. Y. Park
Activation of Caspase-8 Contributes to 3,3'-Diindolylmethane-Induced Apoptosis in Colon Cancer Cells
J. Nutr., January 1, 2007; 137(1): 31 - 36.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. Y. Lim, Y. Jeong, A. L. Tyner, and J. H. Y. Park
Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin
Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G66 - G75.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. B. Ewaschuk, J. W. Walker, H. Diaz, and K. L. Madsen
Bioproduction of Conjugated Linoleic Acid by Probiotic Bacteria Occurs In Vitro and In Vivo in Mice
J. Nutr., June 1, 2006; 136(6): 1483 - 1487.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. J. Cho, E. J. Kim, S. S. Lim, M. K. Kim, M.-K. Sung, J.-S. Kim, and J. H. Y. Park
Trans-10,cis-12, Not cis-9,trans-11, Conjugated Linoleic Acid Inhibits G1-S Progression in HT-29 Human Colon Cancer Cells
J. Nutr., April 1, 2006; 136(4): 893 - 898.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
X. Lu, J. i. Jung, H. J. Cho, D. Y. Lim, H. S. Lee, H. S. Chun, D. Y. Kwon, and J. H. Park
Fisetin Inhibits the Activities of Cyclin-Dependent Kinases Leading to Cell Cycle Arrest in HT-29 Human Colon Cancer Cells
J. Nutr., December 1, 2005; 135(12): 2884 - 2890.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. J Field and P. D Schley
Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids
Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1190S - 1198S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. J. Kim, I.-J. Kang, H. J. Cho, W. K. Kim, Y.-L. Ha, and J. H. Y. Park
Conjugated Linoleic Acid Downregulates Insulin-Like Growth Factor-I Receptor Levels in HT-29 Human Colon Cancer Cells
J. Nutr., August 1, 2003; 133(8): 2675 - 2681.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1979 by the American Physiological Society.